Closter, NJ, United States of America

Bitao Liang

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bitao Liang

Introduction

Bitao Liang, a prominent inventor based in Closter, NJ, has made significant strides in the field of cellular biology and immunotherapy. With a portfolio of nine patents, he is recognized for his innovative methodologies in T lymphocyte production and modification, contributing to advanced cancer treatment and viral infection therapies.

Latest Patents

Among Bitao Liang's latest patents are groundbreaking technologies that enhance T cell production. One notable patent describes methods of generating cytotoxic T lymphocytes directly from peripheral blood mononuclear cells without the need for separate antigen-presenting cell isolation, utilizing a single round of antigen stimulation. This efficient process not only facilitates the generation of T cells but also opens avenues for their application in treating cancer and viral infections. Additionally, he has developed modified T lymphocytes that express artificial cell death polypeptides, designed to induce apoptosis in targeted cells. This innovative approach allows such modified T cells to be utilized as treatments for diseases like cancer.

Career Highlights

Bitao Liang has held positions at notable companies such as Celgene Corporation and Anthrogenesis Corporation. His work in these organizations has served as a foundation for his inventive contributions, where he has been at the forefront of developing novel therapeutic strategies through cellular engineering and manipulation.

Collaborations

Throughout his career, Liang has collaborated with esteemed colleagues, including Stewart Abbot and Tianjian Li. These partnerships have facilitated the exchange of ideas and accelerated the research and development of innovative treatments, ultimately benefiting patients in need of advanced medical solutions.

Conclusion

Bitao Liang's inventive work in the realm of T lymphocytes exemplifies his dedication to advancing medical technology for improved therapies. His patents reflect a commitment to innovation, showcasing methods that not only enhance T cell production but also broaden the scope of immunotherapy. As research continues to evolve, Liang's contributions may pave the way for new treatments, fortifying his legacy as a significant figure in the field of biomedical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…